Cargando…

Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility

This commentary attempts to discuss the required standardization of circulating tumor DNA (ctDNA) analyses and thereby improve the clinical validity of ctDNA monitoring in the metastatic setting of solid tumors.

Detalles Bibliográficos
Autores principales:	Brenner Thomsen, Caroline, Dandanell Juul, Amanda, Lefèvre, Anna Cecilie, Glismand Truelsen, Christina, Dizdarevic, Edina, Ryssel, Heidi, Mathilde Kjær, Ina, Lycke Wind, Karen, Callesen, Louise Bach, Faaborg Larsen, Louise, Støchkel Frank, Malene, Fredslund Andersen, Rikke, Garm Spindler, Karen‐Lise, Jakobsen, Anders
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543969/ https://www.ncbi.nlm.nih.gov/pubmed/35302663 http://dx.doi.org/10.1002/cncr.34168

Ejemplares similares

Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy
por: Truelsen, Christina Glismand, et al.
Publicado: (2022)

Circulating DNA and frequency of colorectal cancer brain metastases in a presumed high-risk group
por: Callesen, Louise Bach, et al.
Publicado: (2023)

Pelvic Insufficiency Fractures and Bone Pain after Radiation Therapy for Anal Cancer: Relation to Pelvic Bone Dose-Volume Parameters
por: Kronborg, Camilla Jensenius, et al.
Publicado: (2022)

Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
por: Spindler, Karen Lise Garm, et al.
Publicado: (2015)

Nonplatinum‐based therapy with Paclitaxel and Capecitabine for advanced squamous cell carcinomas of the anal canal: A population‐based Danish anal cancer group study
por: Truelsen, Christina Glismand, et al.
Publicado: (2021)

Time for a lead-time definition? Author response to ‘Why the length of recurrence free survival or “lead-times” can be misleading. Comment on: Callesen LB, Takacova T, Hamfjord J, et al. Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis’
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)

Estimated dose to site of loco-regional recurrence after radiotherapy in anal cancer using point of origin methods
por: Lycke Wind, Karen, et al.
Publicado: (2023)

Intensified Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Anus—A Population-Based Experience from the Danish Anal Cancer Group
por: Wind, Karen Lycke, et al.
Publicado: (2021)

Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
por: Faaborg, Louise, et al.
Publicado: (2022)

Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer
por: Spindler, Karen-Lise Garm, et al.
Publicado: (2023)

The Clinical Impact of Methylated Homeobox A9 ctDNA in Patients with Non-Resectable Biliary Tract Cancer Treated with Erlotinib and Bevacizumab
por: Andersen, Line Bechsgaard, et al.
Publicado: (2022)

The Clinical Value of Measuring Circulating HPV DNA during Chemo-Radiotherapy in Squamous Cell Carcinoma of the Anus
por: Lefèvre, Anna C., et al.
Publicado: (2021)

The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
por: Dizdarevic, Edina, et al.
Publicado: (2022)

Actionable Molecular Alterations Are Revealed in Majority of Advanced Non-Small Cell Lung Cancer Patients by Genomic Tumor Profiling at Progression after First Line Treatment
por: Frank, Malene Støchkel, et al.
Publicado: (2021)

Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
por: Callesen, Louise B., et al.
Publicado: (2022)

Fractionated palliative thoracic radiotherapy in non-small cell lung cancer – futile or worth-while?
por: Støchkel Frank, Malene, et al.
Publicado: (2018)

Systematic review: brain metastases from colorectal cancer—Incidence and patient characteristics
por: Christensen, Troels Dreier, et al.
Publicado: (2016)

Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
por: Kjær, Ina Mathilde, et al.
Publicado: (2023)

EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
por: Spindler, Karen-Lise G, et al.
Publicado: (2011)

Innate immune function during antineoplastic treatment is associated with 12-months survival in non-small cell lung cancer
por: Ryssel, Heidi, et al.
Publicado: (2022)

Colorectal cancer, comorbidity, and risk of venous thromboembolism: assessment of biological interactions in a Danish nationwide cohort
por: Ahern, Thomas P, et al.
Publicado: (2016)

Prognostic importance of circulating epidermal growth factor-like domain 7 in patients with metastatic colorectal cancer treated with chemotherapy and bevacizumab
por: Hansen, Torben Frøstrup, et al.
Publicado: (2017)

Differences in Administration of Methotrexate and Impact on Outcome in Low-Risk Gestational Trophoblastic Neoplasia
por: Wallin, Emelie, et al.
Publicado: (2022)

The Prognostic Value of Haplotypes in the Vascular Endothelial Growth Factor A Gene in Colorectal Cancer
por: Hansen, Torben F., et al.
Publicado: (2010)

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing
por: Demuth, Christina, et al.
Publicado: (2018)

Association between the expression of microRNAs and the response of patients with locally advanced rectal cancer to preoperative chemoradiotherapy
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2017)

NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer
por: Raunkilde, Louise, et al.
Publicado: (2022)

Quantification of Cell-Free HER-2 DNA in Plasma from Breast Cancer Patients: Sensitivity for Detection of Metastatic Recurrence and Gene Amplification
por: Sørensen, Patricia Diana, et al.
Publicado: (2015)

Breast cancer in the Arctic – changes over the past decades
por: Fredslund, Stine Overvad, et al.
Publicado: (2012)

Melatonin for sleep disorders in children with neurodevelopmental disorders: protocol for a systematic review with meta-analysis and Trial Sequential Analysis of randomised clinical trials
por: Jørgensen, Caroline Kamp, et al.
Publicado: (2022)

MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer
por: Eriksen, Anne Haahr Mellergaard, et al.
Publicado: (2016)

The prognostic value of simultaneous tumor and serum RAS/RAF mutations in localized colon cancer
por: Thomsen, Caroline Emilie B., et al.
Publicado: (2017)

Reconstitution and post-thaw storage of cryopreserved human mesenchymal stromal cells: Pitfalls and optimizations for clinically compatible formulants
por: Aabling, Rasmus Roost, et al.
Publicado: (2023)

Lectures given at the Ion Implantation School in Connection with 4th International Conference on Ion Implantation : Equipment and Techniques
por: Ryssel, Heiner, et al.
Publicado: (1982)

Proceedings of the 4th International Conference on Ion Implantation : Equipment and Techniques
por: Ryssel, Heiner, et al.
Publicado: (1983)

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer
por: Jensen, Lars Henrik, et al.
Publicado: (2019)

Pyoderma Gangrenosum: A Retrospective Study of Clinical Characteristics, Comorbidities, Response to Treatment and Mortality Related to Prednisone Dose
por: SCHØSLER, Louise, et al.
Publicado: (2021)

Optimal Insertion Depth for Nasal Mid-Turbinate and Nasopharyngeal Swabs
por: Callesen, Rasmus Eið, et al.
Publicado: (2021)

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial
por: Larsen, Julie Rask, et al.
Publicado: (2014)

Menomini women and culture change /
por: Spindler, Louise S.
Publicado: (1962)

Cannot write session to /tmp/vufind_sessions/sess_ojs0ogumugvbvebqtcd7is1biq